1. Impact of administration of nicorandil prior to percutaneous coronary intervention in treatment of acute myocardial infarction
   Weijun Li et al, 2021, Medicine CrossRef
2. Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis
   Jin Zhou et al, 2020, Journal of International Medical Research CrossRef
3. Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
   Himanshu Gupta et al, 2022, Cureus CrossRef
4. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
   Ning Geng et al, 2021, BMC Cardiovascular Disorders CrossRef
5. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis
   Zhenjun Ji et al, 2020, Irish Journal of Medical Science (1971 -) CrossRef
6. Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention
   Ming-Dong Gao et al, 2020, Chinese Medical Journal CrossRef
7. Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials
   Liye Shi et al, 2020, American Journal of Cardiovascular Drugs CrossRef
8. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
   Chunguang Feng et al, 2019, Heart, Lung and Circulation CrossRef
9. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
   Xiao-Tao Zhao et al, 2019, BMC Cardiovascular Disorders CrossRef
10. Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction
    Zheng-Dong Wang et al, 2022, Clinical and Applied Thrombosis/Hemostasis CrossRef
11. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis
    Jiaying Li et al, 2019, Expert Opinion on Drug Safety CrossRef
12. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI
    Zheng-Dong Wang et al, 2021, Clinical Hemorheology and Microcirculation CrossRef
13. Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes
    Binjie Sun et al, 2017, Medicine CrossRef
14. DOES PERIPROCEDURAL NICORANDIL IMPROVE CARDIOVASCULAR OUTCOMES IN ACUTE MYOCARDIAL INFARCTION? - META-ANALYSIS
    Luxitaa Goenka et al, 2016, Journal of Evidence Based Medicine and Healthcare CrossRef
15. Update on the sources, pharmacokinetics, pharmacological action, and clinical application of anisodamine
    Yuan Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
16. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis
    Xiaowei Niu et al, 2018, BMC Cardiovascular Disorders CrossRef
17. Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients
    Su An et al, 2021, Medicine CrossRef
18. Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Xingli Xu et al, 2019, Experimental and Therapeutic Medicine CrossRef